Evidence map›Paper›PMID 37334886›Full record

ArticleMicrobiology (Reading, England)2023

Inoculum-dependent bactericidal activity of a

Bryan Berube, Aditi Deshpande, Amala Bhagwat, Tanya Parish

Abstract read
In one paragraph

Article in Microbiology (Reading, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Bryan BerubeCenter for Global Infectious Disease, Seattle Children's Research Institute, Seattle, WA, USA.
Aditi DeshpandeCenter for Global Infectious Disease, Seattle Children's Research Institute, Seattle, WA, USA.
Amala BhagwatCenter for Global Infectious Disease, Seattle Children's Research Institute, Seattle, WA, USA.
Tanya ParishCenter for Global Infectious Disease, Seattle Children's Research Institute, Seattle, WA, USA.

Funding

The role of Esx-3 in mediating drug resistanceR01AI129360 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI PARISH, TANYA · 2018 to 2022
$1.8M
NIAID NIH HHS R01 AI129360
6 · The paper itself

Abstract

Indolcarboxamides are a promising series of anti-tubercular agents, which target

Indexed as

Mycobacterium tuberculosisAntitubercular AgentsBacterial ProteinsIsoniazidMembrane Transport ProteinsMicrobial Sensitivity TestsAntitubercular AgentsBacterial ProteinsIsoniazidMembrane Transport Proteinsanti-tubercularbactericidal activitycell-wall inhibitortuberculosis drug discovery

Identifiers

PMID37334886
PMCPMC10333795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.